A clinical case of late manifestation of celiac disease concurrent with another autoimmune disease

DOI: https://doi.org/10.29296/25877305-2023-05-10
Issue: 
5
Year: 
2023

Professor V. Grinevich, MD; Yu. Kravchuk, MD; E. Ivanyuk, Candidate of Medical Sciences; P. Seliverstov, Candidate of Medical Sciences; Associate Professor
I. Yarovenko, Candidate of Medical Sciences, I. Karagodin; A. Borisova
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia, Saint Petersburg

Celiac disease is a genetically determined disease with its onset in childhood. In November 2021, a 51-year-old female patient was admitted to the Gastroenterology Department with complaints with diarrhea 5 times daily and severe protein-energy malnutrition by the type of senile kwashiorkor. Analysis of her history indicated that in March 2021, the patient took amoxicilline 500 mg twice daily, as prescribed by the local therapist, for 2 weeks, whereupon she noted the appearance of diarrhea that lasted for a month. Moreover, antibiotic-associated diarrhea was ruled out. A celiac-disease-specific histological pattern of the small bowel mucosa was revealed (the ratio of villus height to crypt depth was 1:1), as well as the titer of antibodies to recombinant tissue transglutaminase-2 IgA class >210 U/ml. This could establish a diagnosis of symptomatic celiac disease. During the gluten-free diet, the stool returned to normal; the body weight gradually began to increase. The persistent severe condition in the patient, hypokalemia, skin bronze hue, low aldosterone levels could diagnose primary hypoaldosteronism. Liver biopsy could diagnose small duct primary sclerosing cholangitis. Thus, it is important to note that the onset of celiac disease may occur may occur in people over 50 years of age; whereas primary hypoaldosteronism and primary sclerosing cholangitis may be associated with celiac disease and have a common autoimmune origin.
Keywords: 
gastroenterology
celiac dsease
gluten
hypoaldosteronism
sclerosing cholangitis

References: 
  1. Лазебник Л.Б., Ткаченко Е.И., Орешко Л.С. и др. Рекомендации по диагностике и лечению целиакии взрослых. Экспериментальная и клиническая гастроэнтерология. 2015; 5: 3–12 [Lazebnik L.B., Tkachenko E.I., Oreshko L.S. et al. Guidelines for diagnosis and treatment of celiac disease. Experimental and Clinical Gastroenterology. 2015; 5: 3–12 (in Russ.)].
  2. Породенко Н.В., Скибицкий В.В., Запевина В.В. и др. Типичные и атипичные формы целиакии: трудности диагностики. Кубанский научный медицинский вестник. 2018; 25 (1): 189–94 [Porodenko N.V., Skibitskiy V.V., Zapevina V.V., et al. Typical and atypical forms of celiac desease: difficulties in the diagnosis. Kuban Scientific Medical Bulletin. 2018; 25 (1): 189–94 (in Russ.)]. DOI: 10.25207/1608-6228-2018-25-1-189-194.
  3. Durazzo M., Ferro A., Brascugli I. et al. Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022? J Clin Med. 2022; 11: 258. DOI: 10.3390/jcm11010258
  4. Федеральные клинические рекомендации по оказанию медицинской помощи детям с целиакией. Министерство здравоохранения Российской Федерации, Союз педиатров России. 2015 r ID KP404 [Federal clinical guidelines for the provision of medical care to children with celiac disease. Ministry of Health of the Russian Federation, the Union of Pediatricians of Russia. 2015 red KP 404 (in Russ.)]. URL: https://mosgorzdrav.ru/ru-RU/science/default/download
  5. Парфенов А.И., Крумс Л.М., Сабельникова Е.А. Глютенчувствительная целиакия и профилактика аутоиммунных и онкологических заболеваний. Тер арх. 2007; 2: 5–11 [Parfenov A.I., Krums L.M., Sabelnikova E.A. Gluten-sensitive celiac disease and prevention of autoimmune and oncological diseases. Ter arkh. 2007; 2: 5–11 (in Russ.)].
  6. Lionetti E., Catassi C. New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int Rev Immunol. 2011; 30 (4): 219–31. DOI: 10.3109/08830185.2011.602443
  7. Леденцова С.С., Гуляев Н.И., Ситкин C.И. и др. Акне как внекишечное проявление целиакии. Подходы к терапии. Медицинский совет. 2020; 21: 126–35 [Ledentsova S.S., Gulyaev N.I., Sitkin S.I. et al. Acne as a common extraintestinal manifestation of celiac disease. treatment approaches. Medical Council. 2020; 21: 126–35 (in Russ.)]. DOI: 10.21518/2079-701X-2020-21-126-135
  8. O'Leary C., Walsh C.H., Wiencke P. et al. Celiac disease and autoimmune Addison's disease: a clinical pitfall. QJM. 2002; 95: 79–82. DOI: 10.1093/qjmed/95.2.79
  9. Lebwohl B. Epidemiology, Presentation, and Diagnosis of Celiac Disease / Lebwohl B, Rubio-Tapia A. Gastroenterology. 2021; 160 (1): 63–75. DOI: 10.1053/j.gastro.2020.06.098
  10. Леденцова С.С., Гуляев Н.И., Ключерева С.В. и др. Зонулин как показатель проницаемости кишечника у пациентов с акне на фоне целиакии. Врач. 2023; 34 (1): 59–63 [Ledentsova S., Gulyaev N., Klyuchereva S. et al. Zonulin as a marker of intestinal permeability in patients with acne associated with celiac disease. Vrach. 2023; 34 (1): 59–63 (in Russ.)]. DOI: 10.29296/25877305-2023-01-13
  11. Гриневич В.Б., Кравчук Ю.А., Сас Е.И. Эволюция понятия микробно-тканевого комплекса кишечника. Экспериментальная и клиническая гастроэнтерология. 2020; 183 (11): 4–10 [Grinevich V.B., Kravchuk Yu.A., Sas E.I. The evolution of the concept of the intestinal microbial-tissue complex. Experimental and Clinical Gastroenterology. 2020; 183 (11): 4–10 (in Russ.)]. DOI: 10.31146/1682-8658-ecg-183-11-4-10
  12. Каминарская Ю.А. Целиакия, аллергия к пшенице, нецелиакийная чувствительность к глютену: актуальные вопросы патогенеза и диагностики глютенассоциированных заболеваний. Клиническое питание и метаболизм. 2021; 2 (3): 113–24 [Kaminarskaya Yu.A. Celiac disease, wheat allergy, non-celiac gluten sensitivity: topical issues of pathogenesis and diagnosis of gluten-associated diseases. Clinical nutrition and metabolism. 2021; 2 (3): 113–24 (in Russ.)]. DOI: 10.17816/clinutr90770
  13. Вохмянина Н.В., Гайковая Л.Б., Павлова Р.Н. Целиакия: от метаболических нарушений к генетике и эпигенетике (научный обзор). Профилактическая и клиническая медицина. 2022; 2 (83): 89–96 [Vokhmyanina N.V., Gaikovaya L.B., Pavlova R.N. Сeliac disease: from metabolic disorders to genetics and epigenetics (review). Preventive and clinical medicine. 2022; 2 (83): 89–96 (in Russ.)]. DOI: 10.47843/2074-9120_2022_2_89
  14. Glissen Brown J.R., Singh P. Coeliac disease. Paediatr Int Child Health. 2019; 39 (1): 23–31. DOI: 10.1080/20469047.2018.1504431
  15. Klemm N., Gooderham M.J., Papp K. Could it be gluten? Additional skin conditions associated with celiac disease. Int J Dermatol. 2022; 61 (1): 33–8. DOI: 10.1111/ijd.15750
  16. Bragde H., Jansson U., Fredrikson M. et al. Celiac disease biomarkers identifi ed by transcriptome analysis of small intestinal biopsies. Cell Mol Life Sci. 2018; 75: 4385–401.DOI: 10.1007/s00018-018-2898-5
  17. Espino L., Núñez C. The HLA complex and coeliac disease. Int Rev Cell Mol Biol. 2021; 358: 47–83. DOI: 10.1016/bs.ircmb.2020.09.009
  18. Gnodi E., Meneveri R., Barisani D. Celiac disease: From genetics to epigenetics. World J Gastroenterol. 2022; 28 (4): 449–63. DOI: 10.3748/wjg.v28.i4.449